Optimal design and endpoint of clinical trials using immune checkpoint blocking agents. Issue 12 (1st December 2016)

Record Type:: Journal Article
Title:: Optimal design and endpoint of clinical trials using immune checkpoint blocking agents. Issue 12 (1st December 2016)
Main Title:: Optimal design and endpoint of clinical trials using immune checkpoint blocking agents
Authors:: Keam, Bhumsuk
Jung, Hun
Nam, Byung Ho
Abstract:
Is Part Of:: Expert review of anticancer therapy. Volume 16:Issue 12(2016)
Journal:: Expert review of anticancer therapy
Issue:: Volume 16:Issue 12(2016)
Issue Display:: Volume 16, Issue 12 (2016)
Year:: 2016
Volume:: 16
Issue:: 12
Issue Sort Value:: 2016-0016-0012-0000
Page Start:: 1217
Page End:: 1218
Publication Date:: 2016-12-01
Subjects:: Immune checkpoint blocking agents -- PD-1 -- PD-L1 -- endpoint -- clinical trial design
Cancer -- Treatment -- Periodicals
616.99406
Journal URLs:: http://informahealthcare.com ↗
http://www.future-drugs.com/loi/era ↗
DOI:: 10.1080/14737140.2016.1248945 ↗
Languages:: English
ISSNs:: 1473-7140
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3842.002982
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 11932.xml